Valneva Reports Positive Phase 2 Results in Children for its Chikungunya Vaccine and Announces Phase 3 Dose Decision
Valneva’s vaccine was highly immunogenic in both dose groups. A full dose of the vaccine exhibited a more robust immune response compared to a half dose by providing protective antibody titers already ...
Valneva reports Phase 2 results in children for its chikungunya vaccine
Valneva (VALN) announced results for its Phase 2 clinical trial evaluating the safety and immunogenicity of two different dose levels of its ...
SciELO26d
Chikungunya chronic arthralgia: impact on general and mental health and absenteeism from work
The laboratory diagnosis of acute chikungunya was made by the CDC TRIOPLEX RT-qPCR, which detects CHIKV, dengue (DENV) and Zika viruses (ZIKV) RNA 7, or by detection of anti-CHIKV IgM antibodies using ...
Indiatimes27d
Chikungunya patients back in care as symptoms linger
Maharashtra witnessed a significant rise in chikungunya cases this year, with 5,757 infections. Patients are experiencing prolonged after-effects like joint pain, fatigue, and neurological ...
Indiatimes1mon
Malaria cases nearly double compared to last year, chikungunya also surges
The number of chikungunya cases also saw a surge, with 259 cases till Dec 21, compared to 53 in 2023 and 47 in 2022. Dengue cases in the city reached 6,287 till Dec 24, which is lower than the ...
Medscape10y
Chikungunya: Out of Africa, at Our Front Door
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...